WSU Heme-Onc Cell Lines

Type:Cell Products
SUBTYPE:Immortalized Cancer Cell Lines
APPLICATION & SPECIALITY USES:Biomarker DiscoveryImmuno-oncologyPersonalized Medicine
Keywords:Heme-oncology Cancer Cell LinesWSU-AMLWSU-DLCL2WSU-FSCCLWSU-Heme-Onc Cancer Cell LinesWSU-WM



All WSU human cell lines were developed by Drs. Ayad Al-Katib and Ramzi Mohammad at the Barbara Ann Karmanos Cancer Institute of Wayne State University.


An aggressive human AML cell line established from the frozen peripheral blood of a patient with AML. The cell line showed a partial interstitial deletion of the long arm (q) of chromosome 9. Phenotypically, the cell line is consistent with a diagnosis of M7 AML


A human diffuse large cell lymphoma cell line that is a mature B-cell line (IgG lambda) which is negative for EBV nuclear antigen and expresses the multidrug resistance phenotype. The cell line also has t (14; 18) (q32; q21) as well as other chromosomal aberrations.


A human B-cell line established from an EBV-negative, low-grade follicular, small, cleaved cell lymphoma in leukemic phase.


A human cell line established from the pleural effusion of a patient with IgMλ Waldenstrom macroglobulinemia (WM), a human B-cell tumor

Features & Benefits

  • Each cell line purchased includes clinical data delivered with the cell aliquots.
  • Our stringent quality control processes requires authentication including sterility testing, viability, and plating efficiency determined by lot.
  • Immortalized cell lines are cryopreserved in 1 x 106 ampules.

Click here to view our complete cancer associated cell product inventory that’s ready to ship today!

Use Biosafety Level 1 safety procedures when handling the WSU Heme=Onc Cell Lines.

The WSU Heme-Onc Cell Lines are grown in antibiotic-free medium and monitored for bacterial contamination. The cell line cultures have tested mycoplasma-negative.